9
Views
2
CrossRef citations to date
0
Altmetric
Review

Pharmacoeconomics of antipsychotic medications

&
Pages 13-21 | Published online: 09 Jan 2014
 

Abstract

Antipsychotic medications play a central role in the treatment of schizophrenia and other psychotic disorders. In the last decade, second-generation antipsychotic agents have been introduced that are more expensive on a cost per daily dose basis than older agents. We review empirical data showing trends in prescribing patterns of first- and second-generation antipsychotic agents in the USA and the cost implications of these trends. We show how drug acquisition costs fit into the matrix of overall treatment costs, including pharmacy costs, in and out patient treatment and laboratory costs. We examine specific incentives that influence payers in these various domains and consider how incentives and policies might be constructed so that they serve to encourage effective treatment.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.